A Study to Asses Efficacy, Safety and Tolerability of Monthly Long-acting IM Injection of GA Depot in Subjects With RMS

NCT04121221 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1016

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis, Relapsing-Remitting

Interventions

DRUG: GA Depot
OTHER: Placebo

Sponsor

Mapi Pharma Ltd.